April 25, 2024
Growing demand for anesthesia services at ASCs is being met with a dwindling supply of anesthesia providers....
This website uses cookies. to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept & Close”, you consent to our use of cookies. Read our Privacy Policy to learn more.
By: Jennifer Amedio
Published: 11/6/2020
Postoperative nausea and vomiting is the last thing patients want to deal with when they're recovering from surgery. Waking up in the PACU feeling sick can ruin any good feelings they might have had about a successful procedure and the care your team provided. PONV can also lead to concerns more serious than satisfaction scores: prolonged post-op stays, unanticipated hospital admissions, wound dehiscence, aspiration, esophageal ?tears, electrolyte imbalance and an overall delay in a return to functional ability. Thankfully, there are several effective and economical ways to prevent PONV, especially if you're willing to think outside the box.
Anesthesia providers play an important role in preventing PONV, because they can employ regional blocks before surgery begins. They might also administer antiemetics — metoclopramide, cyclizine, prochlorperazine, droperidol, ondansetron or dexamethasone — prior to and during surgery, especially to patients who present with risk factors associated with PONV.
Before adding aromatherapy to our PONV-prevention protocols, we decided to test its effectiveness on more than 300 patients. When patients arrived in PACU, they were asked to rate their nausea from 0 to 10, with 10 being the worst. After three to five minutes of using aromatherapy inhalers, patients were asked to again rate their nausea. The average pre-intervention score was 6.11; the average post-intervention score was reduced to 2.82. We also found that 37% of patients who were treated with aromatherapy did not need any additional treatment. In fact, we also saw a significant reduction in the use of antiemetics prescribed because of aromatherapy. In three months, we were able to save 43 doses of promethazine and 34 doses of ondansetron.
Now, if a patient wakes up feeling nauseous, we ask them if they would like to try aromatherapy and have found that many are willing. We lay the aromatherapy inhaler on the chests of patients who are still groggy from surgery, but more alert patients can hold it right up to their noses and breathe in the scent.
Patients are aware of alternative therapies and are interested in what they offer.
The inhaler is a blend of four pure and natural essential oils — lavender, peppermint, ginger and spearmint — all of which are known to have therapeutic effects on nausea. Some of the perks of the aromatherapy inhalers are that they're disposable and the scent lasts for up to two hours. The cost per inhaler is only about $2. Nausea is one of those tricky things to treat because it comes and goes, but the convenience of the inhaler lets patients take it home with them once they're discharged to use again if they start to feel queasy.
Depending on your patient's total number of risk factors, the occurrence of PONV can be as high as 87%. Research has shown women, nonsmokers, and patients who are administered volatile anesthetics and post-op opioids are at increased risk. Abdominal surgery is another risk factor because surgeons are working near nerves of the stomach. The high incidence of PONV following open abdominal or intra-abdominal laparoscopic surgery may be due to the release of serotonin, also known as 5-hydroxytryptamine (5-HT). It plays a key role in the development of PONV in many situations, because close to 90% of the body's ?serotonin ?is made in the digestive tract.
Patients are aware of alternative therapies and are interested in what they offer. The great thing about using these therapies to manage PONV risk factors is they're easy to administer and inexpensive. They're a great way to give your nursing staff more autonomy, which promotes better patient outcomes. It is important to educate your staff and to let them witness the effectiveness of these treatments. If they can see that they are beneficial to the patient, they'll be more receptive to adding them to their repertoire. OSM
Growing demand for anesthesia services at ASCs is being met with a dwindling supply of anesthesia providers....
Improvements in both workflow and staff attitudes are part of a leader’s responsibilities, but your interventions in these areas don’t need to be major to make...
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....